semaglutide vs placebo Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial Two-year effects of semaglutide in

GLP-1 agonist liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice

December 2025: The Judicial Panel on Multidistrict Litigation (JPML) has approved a new group lawsuit for people who experienced vision loss after taking Mounjaro and other GLP-1s

To understand why this matters, we have to look at the challenges of human digestion

Each week, participants will engage in discussions on various important topics, including personalized exercise routines, the significance of quality sleep, and comprehensive nutrition counseling

Khoo KS, Lee SY, Ooi CW, Fu X, Miao X, Ling TC, Show PL (2019) Recent advances in biorefinery of astaxanthin from Haematococcus pluvialis

The ADA 2025 oral-presentation abstract (143-OR, published in the journal Diabetes ) is titled "NA-931, a Novel Quadruple IGF-1, GLP-1, GIP, and Glucagon Receptor Agonist Reduces Body Weight without Muscle Loss." Second, the format